Ratings Givaudan SA

Equities

GIVN

CH0010645932

Market Closed - Swiss Exchange Other stock markets 11:30:41 2024-05-31 am EDT			5-day change	1st Jan Change
4,237 ^CHF	+0.78%		+0.28%	+21.61%

May. 29	GIVAUDAN AG : JP Morgan remains Neutral	ZD
May. 28	GIVAUDAN AG : Deutsche Bank reiterates its Neutral rating	ZD

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
According to Refinitiv, the company's ESG score for its industry is good.

Strengths

The group's high margin levels account for strong profits.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.

Weaknesses

The company is in debt and has limited leeway for investment
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.73 times its estimated earnings per share for the ongoing year.
Based on current prices, the company has particularly high valuation levels.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The valuation of the company is particularly high given the cash flows generated by its activity.
The company is not the most generous with respect to shareholders' compensation.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
GIVAUDAN SA	+21.61%	43.27B	B+
ECOLAB INC.	+17.07%	66.31B	A-
SIKA AG	-0.29%	48.46B	A-
FUJIFILM HOLDINGS CORPORATION	+26.72%	27.41B	A-
EMS-CHEMIE HOLDING AG	+9.25%	19.26B	C+
SYMRISE AG	+9.75%	16.58B	B+
CELANESE CORPORATION	-2.14%	16.61B	B+
ALBEMARLE CORPORATION	-15.01%	14.41B	C+
POSCO FUTURE M CO., LTD.	-30.22%	14.02B	A-
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-22.45%	13.34B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes